Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review Kamel LaribiMohamad SobhAlix Baugier de Materre Review Article 02 April 2021 Pages: 1359 - 1376
What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)? Steffen T. SimonAnne PralongMarco Herling Review Article Open access 06 May 2021 Pages: 1377 - 1389
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Xiaoyin BuJinman ZhongBaohong Ping Review Article Open access 11 March 2021 Pages: 1391 - 1400
Neutrophil gelatinase–associated lipocalin as a biomarker of nephropathy in sickle cell disease Rajaa MaroufAdekunle D. AdekileOlusegun A. Mojiminiyi Original Article Open access 02 April 2021 Pages: 1401 - 1409
Frequency of bacteremia in patients with sickle cell disease: a longitudinal study Jaffar A. Al-TawfiqAli A. RabaanMohammed H. AlEdreesi Original Article 17 April 2021 Pages: 1411 - 1416
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients Dinesh BhuraniJyotsna KapoorPallavi Mehta Original Article 03 April 2021 Pages: 1417 - 1427
Presentation of two new mutations in the 3′untranslated region of the β-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey Abdullah ArpaciBahar Unlu GulHasan Kaya Original Article 13 April 2021 Pages: 1429 - 1438
Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients Jacqueline S. GonzálezMaría Agustina PerusiniCarolina B. Belli Original Article 01 May 2021 Pages: 1439 - 1449
Stanozolol for the treatment of anemic lower-risk myelodysplastic syndromes without del(5q) after failure of epoetin alfa: findings from a retrospective study Wei-ying QuLin ZhaoYi-han Zhao Original Article 10 April 2021 Pages: 1451 - 1457
CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia Yi QianYan ChenXiaoming Li Original Article Open access 06 April 2021 Pages: 1459 - 1461
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q) Anna HechtJulia A. MeyerDaniel Nowak Original Article Open access 27 April 2021 Pages: 1463 - 1471
Tissue factor–bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study Hongli ZhaoJiayue SunYingmei Zhang Original Article 24 April 2021 Pages: 1473 - 1483
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells Zhihong ZengCharlie LyMarina Konopleva Original Article 31 March 2021 Pages: 1485 - 1496
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients María P. Martínez SánchezJuan Eduardo Megías-Vericaton behalf of the PETHEMA group Original Article 29 April 2021 Pages: 1497 - 1508
Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphoma Zhiyuan ZhouLei ZhangMingzhi Zhang Original Article 26 April 2021 Pages: 1509 - 1516
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience Sandra Bašić-KindaIvo RadmanIgor Aurer Original Article 20 November 2020 Pages: 1517 - 1524
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial M. PicardiC. CavaliereF. Pane Original Article Open access 28 April 2021 Pages: 1525 - 1535
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns Sophia DanhofLeo RascheElena Gerhard-Hartmann Original Article Open access 11 February 2021 Pages: 1537 - 1546
Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone Qian-qian CaiXue-min GaoJian Li Original Article 10 April 2021 Pages: 1547 - 1552
Long-term outcome after allogeneic stem cell transplantation in multiple myeloma Sini LuomaRaija SilvennoinenAnne Nihtinen Original Article Open access 17 April 2021 Pages: 1553 - 1567
Allogeneic stem cell transplantation for mantle cell lymphoma—update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74) William H. KrügerCarsten HirtChristian A. Schmidt Original Article Open access 08 April 2021 Pages: 1569 - 1577
Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study Yue LuYan-Li ZhaoDao-Pei Lu Original Article 24 November 2020 Pages: 1579 - 1591
Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis Sarah WeberAaron MaghBjörn Steffen Original Article Open access 03 May 2021 Pages: 1593 - 1602
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO) Annika Y. ClassenLarissa HenzeJörg Janne Vehreschild Original Article Open access 13 April 2021 Pages: 1603 - 1620
A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation Ken SasakiAkira HondaMineo Kurokawa Letter to the Editor Open access 06 May 2020 Pages: 1621 - 1622
Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone Ivan KrečakIvana RuščićVelka Gverić-Krečak Letter to the Editor 06 January 2021 Pages: 1623 - 1624
Paroxysmal nocturnal haemoglobinuria associated with a novel phosphatidylinositol glycan class A (PIGA) mutation in a patient with Klinefelter syndrome Yotaro TamaiSayaka ItoAtsuhiko Hasegawa Letter to the Editor 08 January 2021 Pages: 1625 - 1627
Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant Amany R. KeruakousPragathi BalakrishnaAdam Asch Letter to the Editor 12 January 2021 Pages: 1629 - 1630
Correspondence in reference to the previously published Epub manuscript: “Murt Ahmet et al. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99: 2671-2677” Marco PicardiClaudia GiordanoFabrizio Pane Letter to the Editor Open access 01 February 2021 Pages: 1631 - 1633
Very rare lineage switch from acute myeloid leukemia with BCR-ABL1 to B-lymphoblastic leukemia Ting LiHongwei ChenLiheng Zheng Letter to the Editor 05 March 2021 Pages: 1635 - 1636
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab Khalid ShoumariyehJohannes JungMonika Engelhardt Letter to the Editor Open access 13 March 2021 Pages: 1637 - 1640
Multifocal osteolytic lesions in hairy cell leukemia—the importance of PET/CT in diagnosis and assessment Pawel RobakDorota Jesionek-KupnickaTadeusz Robak Letter to the Editor 12 June 2020 Pages: 1641 - 1645